Though the small sample size likely prevented us from detecting a significant difference in weight and fat mass change in rapamycin-treated male mice on a HFD, we observed a clear trend ( Supplementary Figure S1 ).
← all excerpts
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition.
1
—
—